Search Weight Loss Topics:




May 27

Hybrid ENDO 2022 press conferences to highlight emerging diabetes, obesity, reproductive research – EurekAlert

Long Term Weight Loss Comments Off on Hybrid ENDO 2022 press conferences to highlight emerging diabetes, obesity, reproductive research – EurekAlert

Researchers will delve into the latest research in diabetes, obesity, thyroid and other endocrine conditions during the Endocrine Societys ENDO 2022 news conferences June 11-14.

The press conferences will feature select abstracts that are being presented at ENDO 2022, the Endocrine Societys annual meeting. The event is being held at the Georgia World Congress Center in Atlanta, Ga. News conferences will be livestreamed for those who are unable to attend in person.

To register to view the news conferences, visit http://www.endowebcasting.com.Journalists can register to attend and learn more about the meeting on our website.

News Conference Schedule:

Saturday, June 11

Endocrine-disrupting Chemicals (noon EDT): Researchers will discuss how chemicals in hair care products affect breast cancer cells in Black women and how chemical exposure in the womb affects fear and anxiety behavior in rats.

Sunday, June 12

Diabetes (10 a.m. EDT): The Society will unveil its Clinical Practice Guideline on Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings. In addition, researchers will explore diabetes effect on metastatic breast cancer outcomes, regional variations in hospitalization for diabetes complications, and prediabetes as a risk factor for heart attacks.

Obesity(11 a.m. EDT): Featured studies will examine long-term weight loss maintenance with medications, how childhood obesity can contribute to male infertility, and the impact of wireless device overuse on obesity.

Monday, June 13

Reproductive Health (9 a.m. EDT): Researchers will discuss the COVID-19 pandemic stresses impact on womens ovulatory cycles, the results of the year-long phase 3 study on hot flash medication fezolinetant, the economic costs of treating mental health disorders in women with polycystic ovary syndrome, and a mouse model of in vitro fertilization in transgender men undergoing active testosterone treatment.

Thyroid Health (11:30 a.m. EDT): Studies will delve into artificial intelligences value for ruling out thyroid cancer, how soon individuals with thyroid conditions can take levothyroxine solution after drinking coffee, and the safety of COVID-19 vaccinations among individuals with hypothyroidism.

Register to attend the news conferences at http://www.endowebcasting.com. Credentialed journalists will be given priority to attend. Recordings will be available on the Societys website following the event.

# # #

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the worlds oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Originally posted here:
Hybrid ENDO 2022 press conferences to highlight emerging diabetes, obesity, reproductive research - EurekAlert

Related Posts

    Your Full Name

    Your Email

    Your Phone Number

    Select your age (30+ only)

    Select Your US State

    Program Choice

    Confirm over 30 years old

    Yes

    Confirm that you resident in USA

    Yes

    This is a Serious Inquiry

    Yes

    Message:



    matomo tracker